How Mounjaro weight loss injections dosage works — and why the steps matter

Step 1: Starting at 2.5 mg, adjustment, not treatment

The first four weeks of Mounjaro are spent at 2.5 mg. This surprises some people. A question our prescribers hear most weeks is: "Is this dose actually doing anything?" The honest answer is that 2.5 mg is calibration, not cure. It keeps nausea and other gastrointestinal effects manageable while your gut receptors adjust to a dual GIP and GLP-1 agonist they haven't encountered before.

During this period you may notice your appetite shifting slightly, but meaningful weight change tends to follow the therapeutic doses rather than this opener. The Mounjaro overview page explains the underlying mechanism in more detail if you'd like to understand how the medicine signals satiety.

Practically speaking: inject subcutaneously into your abdomen, thigh or upper arm on the same day each week. Rotate the site. Keep the pen refrigerated between 2–8 °C. For the precise storage window and full handling instructions, the Mounjaro Patient Information Leaflet (available via the electronic Medicines Compendium (eMC)) is the reference to trust, not secondhand summaries.

Step 2: Moving through 5 mg to 15 mg, reading your response at each rung

After the 2.5 mg starter month, the standard pathway moves to 5 mg, then 7.5 mg, 10 mg, 12.5 mg and finally 15 mg, each held for roughly four weeks before stepping up. "Roughly" is deliberate: your prescriber decides when you're ready, based on how you're tolerating the current dose and what your weight response looks like. The schedule is a guide, not a conveyor belt.

The full weight-loss dosage guide walks through what happens at each level in more detail. What matters here is the principle: the increase is a clinical decision, not an automatic reward for surviving the previous pen. Side effects (nausea, loose stools, reflux, fatigue) tend to resurface briefly with each step, then settle again. Most people find the pattern predictable after the first change.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, found average body-weight reductions of around 20–21% at the 15 mg dose over 72 weeks among adults with obesity. Those results were achieved at the maintenance dose, which is why reaching it (at a pace your body tolerates) matters. If you want to understand how the 5 mg Mounjaro weight loss injections fit into this progression, a dedicated page covers that stage in detail. You can also read about the evidence behind each dosage level on a dedicated page.

Step 3: Finding your maintenance dose, the highest tolerated, not necessarily the highest available

Not everyone reaches 15 mg, and that is completely normal. The licensed goal is the highest dose you tolerate well, which may be 10 mg or 12.5 mg for some people. NICE's appraisal of tirzepatide (TA1026, published in December 2024) notes that if less than 5% weight loss has been achieved after six months at the highest tolerated dose, continuing treatment should be reviewed. This gives patients and prescribers a clear, evidence-based benchmark.

At nume, every repeat order is clinically re-reviewed before it is dispensed, there is no auto-renewal. Think of it like an ongoing conversation rather than a standing order. If you order before midday on a working day and your prescription is approved, your next pen ships the same afternoon and arrives the following working day via DPD, in plain packaging.

If you're weighing up what private treatment actually costs alongside the clinical oversight it provides, the Mounjaro pricing page sets that out clearly. Lower-threshold eligibility can also apply for some ethnic backgrounds under UK clinical guidance, your prescriber works through the full picture at assessment.

Side effects across the dosage schedule, what to expect and when to act

Gastrointestinal symptoms are the most common experience at every dose level, particularly at the start and after increases: nausea, constipation, diarrhoea, indigestion, burping. They typically peak in the first week of a new dose and fade. Staying hydrated, eating smaller portions and avoiding high-fat meals around injection day helps most people through the adjustment.

Some effects warrant prompt medical attention. The MHRA issued guidance in early 2026 highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines: severe stomach pain that spreads to the back, with or without vomiting, is a signal to seek urgent help rather than wait it out. You can report suspected side effects or concerns about any medicine via the Yellow Card scheme.

Injection-site reactions, mild headaches and occasional dizziness round out the common profile. Most people settle into treatment within a few weeks of starting or stepping up. If you're curious about the practicalities of the pen itself, the page covering Mounjaro injections at the 5 mg stage is a useful reference for what to expect when you move beyond the starter dose. And if you'd still like to check whether your starting point (your BMI, any existing conditions) makes you a candidate for Mounjaro, the FAQs page covers the questions our prescribers field most often, and a free consultation is the place to begin.

Check your eligibility with our prescribers, it's free, takes a few minutes, and is reviewed the same day by a real clinician.